Abstract | INTRODUCTION: This study evaluates the efficacy of various antimicrobial treatments for orofacial infections on the basis of pharmacokinetic/pharmacodynamic (PK/PD) criteria. METHODS: A complete a literature search was undertaken to establish the MIC90 values of the five microorganisms most frequently isolated in odontogenic infections and the pharmacokinetic parameters of 13 antibiotics used in these infections. Pharmacokinetic simulations were then carried out with mean population parameters and efficacy indexes were calculated for the 47 treatment regimens analyzed. For drugs showing time-dependent antibacterial killing, the time above MIC (t > MIC) was calculated. For drugs with concentration-dependent bactericidal activity, the AUC/MIC was calculated. RESULTS:
Amoxicillin-clavulanic (500 mg/8 h or 1000 mg/12 h) and clindamycin (300 mg/6 h) in the time-dependent killing group and moxifloxacin (400 mg/24 h) in the concentration-dependent group showed adequate efficacy indexes against the five pathogens considered to be the most commonly implicated in odontogenic infections. The spiramycin plus metronidazole combination, present in the commercial formulation Rhodogyl, did not reach satisfactory PK/PD indexes. CONCLUSION:
|
Authors | Arantxazu Isla, Andrés Canut, Alicia Rodríguez-Gascón, Alicia Labora, Bruno Ardanza-Trevijano, María Angeles Solinís, José Luis Pedraz |
Journal | Enfermedades infecciosas y microbiologia clinica
(Enferm Infecc Microbiol Clin)
Vol. 23
Issue 3
Pg. 116-21
(Mar 2005)
ISSN: 0213-005X [Print] Spain |
Vernacular Title | Análisis farmacocinético/farmacodinámico (PK/PD) de la antibioterapia en odontoestomatología. |
PMID | 15757581
(Publication Type: Comparative Study, Journal Article, Review)
|
Chemical References |
- Anti-Bacterial Agents
- Aza Compounds
- Fluoroquinolones
- Quinolines
- Clindamycin
- Amoxicillin-Potassium Clavulanate Combination
- Moxifloxacin
|
Topics |
- Algorithms
- Amoxicillin-Potassium Clavulanate Combination
(pharmacokinetics, pharmacology, therapeutic use)
- Anti-Bacterial Agents
(pharmacokinetics, pharmacology, therapeutic use)
- Area Under Curve
- Aza Compounds
(pharmacokinetics, pharmacology, therapeutic use)
- Bacterial Infections
(drug therapy)
- Clindamycin
(pharmacokinetics, pharmacology, therapeutic use)
- Clinical Trials as Topic
(methods)
- Dose-Response Relationship, Drug
- Drug Therapy, Combination
(pharmacokinetics, pharmacology, therapeutic use)
- Fluoroquinolones
- Fusobacterium nucleatum
(drug effects)
- Humans
- Microbial Sensitivity Tests
- Mouth Diseases
(drug therapy, microbiology)
- Moxifloxacin
- Peptostreptococcus
(drug effects)
- Periodontitis
(drug therapy, microbiology)
- Porphyromonas gingivalis
(drug effects)
- Prevotella intermedia
(drug effects)
- Quinolines
(pharmacokinetics, pharmacology, therapeutic use)
- Time Factors
- Viridans Streptococci
(drug effects)
|